Last edition
News about Market
Leveragen Teams Up with Daiichi Sankyo for Next-Gen Biologics Innovation
Daiichi Sankyo will collaborate with Leveragen to apply its in-vivo antibody discovery platform across selected research programmes, supporting early-stage and pre-clinical development of antibody-based biologics across multiple therapeutic areas.
Market | 19/03/2026 | By News Bureau | 179
Zydus and Torrent Pharma Sign Licensing Deal to Co-Market Semaglutide in India
Zydus Lifesciences and Torrent Pharmaceuticals have entered a licensing agreement to co-market Semaglutide injection in India, aiming to improve access for patients with poorly controlled Type 2 Diabetes Mellitus and support chronic weight management through advanced, innovative therapy.
Market | 19/03/2026 | By News Bureau | 301
Akums Drugs and Pharmaceuticals introduces DCGI-approved Lasmiditan dispersible tablets, offering faster, patient-friendly migraine relief with improved compliance, especially for patients facing nausea and difficulty swallowing during acute attacks.
Market | 18/03/2026 | By News Bureau | 197
Lupin and Zydus Partner to Co-Market Semaglutide Injection in India
Lupin has secured semi-exclusive rights to co-market Zydus’ Semaglutide injection in India under the brands Semanext and Livarise, while Zydus will continue marketing it under the brand names SEMAGLYNTM, MASHEMATM and ALTERMETM.
Market | 18/03/2026 | By News Bureau | 476
Argo Biopharma's siRNA Therapy BW-20805 Gets FDA Fast Track for HAE
Argo Biopharma has received FDA Fast Track designation for BW-20805, with an ongoing global phase-II study in adult HAE patients and primary completion expected in the second half of 2026.
Market | 17/03/2026 | By News Bureau | 184
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
The collaboration between Aptar Pharma and COVIRIX Medical Partner will focus on a feasibility study to adapt Aptar Pharma’s proprietary Dry Powder Inhalation (DPI) platform for the delivery of COVIRIX Medical’s anti-viral compound.
Market | 16/03/2026 | By News Bureau | 120
Samsung Bioepis and Epis NexLab Partner G2GBIO to Develop Long-Acting Semaglutide
Samsung Bioepis and Epis NexLab have signed a research collaboration and licensing agreement with G2GBIO to develop novel assets, including long-acting semaglutide, using G2GBIO’s proprietary microsphere drug delivery technology.
Market | 16/03/2026 | By News Bureau | 158
Roche Pharma India partners with the Government of Punjab to launch NeuroSakhi, a patient support and awareness programme aimed at improving diagnosis, care pathways and treatment access for women with multiple sclerosis.
Market | 13/03/2026 | By News Bureau | 237
Earendil Labs and WuXi Biologics Partner on Bispecific Antibodies and ADCs
Under the agreement, WuXi Biologics will provide end-to-end development and manufacturing services to Earendil Labs, supporting faster regulatory timelines, reliable CMC execution, and scalable global clinical development.
Market | 13/03/2026 | By News Bureau | 194
Veristat Expands Global Regulatory And Clinical Trial Support For Pharma Companies
Veristat, a global clinical research organization (CRO) and regulatory consultancy, has expanded its regulatory and clinical trial support services to help international pharmaceutical and medical device companies navigate approvals in key global markets, including the United Kingdom, Switzerland, Australia, Canada and the United States.
Market | 12/03/2026 | By Darshana | 143
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy